Clinical Trial Update: Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated riociguat for symptomatic pulmonary hypertension associated with idiopathic interstitial pneumonia, but the study was terminated and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Interstitial Pneumonia
• Pulmonary Hypertension

Drugs mentioned

• Adempas (riociguat)

Snippet

Sponsor: Bayer | Conditions: Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary | Phase 2 | Status: TERMINATED | Results posted: 2017-06-05